| 书目名称 | Glucagon I | | 编辑 | Pierre J. Lefèbvre (Professor of Medicine, Guest P | | 视频video | | | 丛书名称 | Handbook of Experimental Pharmacology | | 图书封面 |  | | 描述 | The Editorial Board of the Handbook of Experimental Pharmacology apparently did not hurry in suggesting production of a volume on glucagon since the present opus is number sixty-six in the series. This fact is even more striking if we consider that 34 volumes published over about eight years will separate the books on glucagon from those on insulin on library shelves, whereas only a few microns separate the cells manufacturing these two polypeptides within the islets of Langerhans in the pancreas! Numerous factors have probably caused this dicrimination; four of them are: First, insulin deficiency or resistance is the cause of one of the most serious and distressing diseases, diabetes mellitus, which affects millions of people, whereas glucagon deficiency is apparently an extremely rare disorder, for which detailed reports are published of individual cases whenever they occur. Second, since its discovery in 1921 by BANTING and BEST, insulin has been irreplaceable for the treatment of the most severe forms of diabetes, whereas, in contrast, glucagon was until recently considered a relatively minor therapeutic agent. Third, whereas insulin is a compound which has been well characteri | | 出版日期 | Book 1983 | | 关键词 | Drogen; Glucagon; Hormone; Hypophyse; Insulin; Prostaglandin; Sepsis; antibody; antigen; chemistry; chromatogr | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-642-68866-9 | | isbn_softcover | 978-3-642-68868-3 | | isbn_ebook | 978-3-642-68866-9Series ISSN 0171-2004 Series E-ISSN 1865-0325 | | issn_series | 0171-2004 | | copyright | Springer-Verlag Berlin Heidelberg 1983 |
The information of publication is updating
|
|
发表于 2025-3-21 17:43:59
